Bafoudiosbulbin B - Compound Card

Bafoudiosbulbin B

Select a section from the left sidebar

Bafoudiosbulbin B

Structure
Zoomed Structure
  • Family: Plantae - Dipterocarpaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Clerodane Diterpene
Canonical Smiles O=C1OC2C[C@H]1[C@]13CC[C@@]4([C@]([C@@H]3C2)(COC1=O)C[C@H](OC4=O)c1cocc1)O
InChI InChI=1S/C20H20O8/c21-15-12-5-11(27-15)6-14-18-7-13(10-1-4-25-8-10)28-17(23)20(18,24)3-2-19(12,14)16(22)26-9-18/h1,4,8,11-14,24H,2-3,5-7,9H2/t11?,12-,13+,14+,18+,19+,20-/m1/s1
InChIKey YBOKWWYNFCUGGA-STSLZHCZSA-N
Formula C20H20O8
HBA 8
HBD 1
MW 388.37
Rotatable Bonds 1
TPSA 112.27
LogP 1.27
Number Rings 6
Number Aromatic Rings 1
Heavy Atom Count 28
Formal Charge 0
Fraction CSP3 0.65
Exact Mass 388.12
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Dioscorea bulbifera Dioscoreaceae Plantae 35874
2 Monotes kerstingii Dipterocarpaceae Plantae 2029430

Showing of synonyms

  • Kuete V, Betrandteponno R, et al. (2012). Antibacterial activities of the extracts, fractions and compounds from Dioscorea bulbifera.. BMC complementary and alternative medicine,2012, 12, 228. [View] [PubMed]
  • Fotso GW, Mogue Kamdem L, et al. (2019). Antimicrobial secondary metabolites from the stem barks and leaves of Monotes kerstingii Gilg (Dipterocarpaceae).. Fitoterapia,2019, 137, 104239. [View] [PubMed]
Pubchem: 102479349

No compound-protein relationship available.

Structure

SMILES: c1occc1C(C2)OC(=O)C(CC3)C2(COC4=O)C5CC(C6)OC(=O)C6C345

Level: 1

Mol. Weight: 388.37 g/mol

Structure

SMILES: C123C4C(=O)OC(C4)CC2C5(COC1=O)C(CC3)C(=O)OCC5

Level: 0

Mol. Weight: 388.37 g/mol

Structure

SMILES: c1ccoc1

Level: 0

Mol. Weight: 388.37 g/mol

Antibacterial

Absorption

Caco-2 (logPapp)
-5.33
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.11
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.17

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.68
Plasma Protein Binding
43.25
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
5.01
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.83
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.0
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
5.74
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-27.67
Rat (Acute)
4.97
Rat (Chronic Oral)
2.13
Fathead Minnow
4.0
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
455.48
Hydration Free Energy
-4.42
Log(D) at pH=7.4
0.85
Log(P)
0.23
Log S
-4.68
Log(Vapor Pressure)
-10.1
Melting Point
292.72
pKa Acid
6.87
pKa Basic
4.95

No predicted protein targets found for this compound.

Download SDF